Author

Yunze Niu

Observed name: Y M Niu

Institutions: Capital Medical University, Beijing Chao-Yang Hospital, Capital Medical University

Observed institutions: Capital Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Chao-Yang Hospital, Capital Medical University, Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences

ORCID: 0009-0006-3683-827X

Observed ORCID: 0009-0006-3683-827X

OpenAlex ID: A5000861652

Patient‐derived organoid‐immune co‐cultures integrated with multi‐omics reveal immunotherapy resistance mechanisms in urothelial carcinoma

2026 · Shan Jiang, Yuxuan Song, et al. · iMeta · 6

SMOC2high myofibroblastic cancer-associated fibroblast drives primary cilia-associated tumor microenvironment remodeling and poor prognosis in gastric cancer

2025 · Qiqi Xu, Changjiang Yang, et al. · Chinese Journal of Cancer Research · 1

Immunotherapy for Digestive System Cancers: Progress, Challenges, and Future Directions

2026 · Keran Sun, Hongru Li, et al. · Biomedicines

Comment on “Comparison of 24-Hour urine parameters before and after initiation of metformin in patients with diabetes and urolithiasis: A retrospective analysis”

2026 · Yunze Niu, Yuxuan Song · Urolithiasis

Cell Death Analysis: A Comprehensive R Package for Multi-pathway Cell Death Analysis in Transcriptomic Data

2026 · Keran Sun, Keqi Jia, et al. · BIO Integration

Evolution’s double-edged sword: SARS-CoV-2 adaptation in HIV reveals nature’s safety valve

2025 · Shaolei Li, Yunze Niu, et al. · The Lancet Microbe

[Pathology and pathogenesis of HIV encephalopathy].

2022 · S M Liu, Y M Niu, et al. · PubMed

Works count: 7

Citation count: 7

H-index: 1

I10-index: